COVID-19 pandemic
The Therapeutic Goods Administration grants provisional approval for the Moderna COVID-19 vaccine for use in children between the ages of 12 and 17.
Sources: 9 News
Changes
- The Therapeutic Goods Administration grants provisional approval to the Moderna COVID-19 vaccine for children aged 12 to 17 years old.
- The Therapeutic Goods Administration grants provisional approval for the Moderna COVID-19 vaccine for use in children between the ages of 12 and 17.